B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature
- PMID: 37455651
- DOI: 10.1080/10428194.2023.2234527
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature
Comment in
-
Lenalidomide maintenance in Myeloma - a goldilocks problem?Leuk Lymphoma. 2023 Oct;64(10):1611-1614. doi: 10.1080/10428194.2023.2255325. Epub 2023 Sep 6. Leuk Lymphoma. 2023. PMID: 37671741 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources